SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India reports Profit after tax of Rs 1807.30 Mln, in the September 2020 quarter

11 Nov 2020 Evaluate
Revenue showed a marginal decline at Rs. 10548.50 millions. For the quarter ended September 2020, as compared to corresponding quarter of last year.Profit for the quarter ended September 2020 increased merely by1.35% to Rs. 1807.30  millions from Rs. 1783.30 millions.The company reported a good operating profit of 2627.70 millions compared to 2330.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202009 201909 % Var 202009 201909 % Var 202003 201903 % Var
Sales 10548.50 10548.00 0.00 21191.20 20536.90 3.19 40931.40 36786.00 11.27
Other Income 220.60 289.00 -23.67 496.90 585.00 -15.06 1143.90 1132.90 0.97
PBIDT 2627.70 2330.30 12.76 5238.20 4368.10 19.92 8708.30 7180.20 21.28
Interest 47.90 18.20 163.19 92.40 38.50 140.00 85.30 22.50 279.11
PBDT 2579.80 2312.10 11.58 5145.80 4329.60 18.85 8623.00 7157.70 20.47
Depreciation 142.90 149.50 -4.41 283.90 297.50 -4.57 596.10 169.20 252.30
PBT 2436.90 2162.60 12.68 4861.90 4032.10 20.58 8026.90 6988.50 14.86
TAX 629.60 379.30 65.99 1251.10 1079.40 15.91 2097.60 2485.20 -15.60
Deferred Tax -19.50 19.70 -198.98 -34.00 11.80 -388.14 14.70 26.40 -44.32
PAT 1807.30 1783.30 1.35 3610.80 2952.70 22.29 5929.30 4503.30 31.67
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 24.91 22.09 12.76 24.72 21.27 16.22 21.28 19.52 9.00

Abbott India Share Price

25577.55 -219.60 (-0.85%)
20-Apr-2026 14:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.90
Dr. Reddys Lab 1235.10
Cipla 1232.95
Zydus Lifesciences 936.50
Lupin 2327.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×